Originally characterized at the University of Florida by the Stephen ORahilly and Robert Kraft groups, the compound has been studied in preclinical research for body composition, adipose tissue lipolysis, glucose homeostasis, skeletal muscle aging, and metabolic disease endpoints
When traveling, keep the vial in original packaging with the pharmacy label visible
The 50 mg lyophilized presentation is well-suited for extended research applications, repeated assay work, formulation screening in laboratory settings, or studies requiring larger quantities of copper peptide reagent
With their extensive experience in surgical recovery, longevity medicine, and hormone optimization, the team takes a structured, evidence-based approach to peptide therapy that prioritizes safety, effectiveness, and measurable outcomes
The material will be used only in a legitimate and documented laboratory protocol